HMIRC Notices - Decisions and Orders

HAZARDOUS MATERIALS INFORMATION REVIEW COMMISSION

January 13, 2007

HAZARDOUS MATERIALS INFORMATION REVIEW ACT

Decisions and orders on claims for exemption

Pursuant to paragraph 18(1)(a) of the Hazardous Materials Information Review Act, the Chief Screening Officer of the Haz-ardous Materials Information Review Commission hereby gives notice of the decisions of the screening officer respecting each claim for exemption and the relevant material safety data sheet (MSDS), listed below.

Claimant	Product Identifier (As shown on the MSDS)	Registry Number	MSDS Preparation Date (As shown on the MSDS)	Date of Decision
Cytec Industries Inc., West Paterson, New Jersey	CYCOM® 5225 Unitape Structural Prepreg	5654	09/15/2004	November 8, 2006
Cytec Industries Inc., West Paterson, New Jersey	CYCOM® 5225 Woven Structural Prepreg	5655	09/15/2004	November 8, 2006
Cytec Industries Inc., West Paterson, New Jersey	CYCOM® 381 Prepreg	5678	07/29/2003	November 8, 2006
GE Betz Inc., Trevose, Pennsylvania	DUSTREAT DC 9140	5709	09-JUN-2004	November 28, 2006
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTE® E-9	5798	07/13/2006	November 29, 2006
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTE® E-4819	5799	7/13/2006	December 4, 2006
Akzo Nobel Surface Chemistry LLC, Chicago, Illinois	REDICOTE® E-4819-3	5800	7/13/2006	December 4, 2006
Cytec Surface Specialties Inc., formerly/ antérieurement UCB Chemicals Corporation, Smyrna, Georgia	PC-1844 Defoamer	5830	09/01/2005	October 10, 2006
Cytec Surface Specialties Inc., formerly/ antérieurement UCB Chemicals Corporation, Smyrna, Georgia	PC-2244 Defoamer	5833	09/01/2005	October 10, 2006
Infineum USA LP, Linden, New Jersey	Infineum T4277	5852	Aug 6, 2004	October 26, 2006
Innospec Fuel Specialties, formerly/ antérieurement Octel Starreon LLC, Newark, Delaware	Starrphyre 1400 formerly/ antérieurement Octel Starreon Starrphyre 1400	5878	01/27/2004	November 27, 2006
Infineum USA LP, Linden, New Jersey	TZ 891B	5889	17Feb2005	November 6, 2006
Infineum USA LP, Linden, New Jersey	TZ 421	5891	Aug 6, 2004	October 26, 2006
Innospec Fuel Specialties, formerly/ antérieurement Octel Starreon LLC, Newark, Delaware	DDA-1858 da1 formerly/ antérieurement Octel Starreon DDA-1858 da1	5896	02/23/2004	November 2, 2006
Chemtura Canada Co/Cie., formerly/ antérieurement Crompton Company/Cie., Elmira, Ontario	MARK 2915	5903	10/25/2005	December 15, 2006
Infineum USA LP, Linden, New Jersey	Infineum T4268A	5906	09 Mar2005	November 6, 2006
Infineum USA LP, Linden, New Jersey	Infineum T4278	5907	21 MAR2005	November 6, 2006
The Lubrizol Corporation, Wickliffe, Ohio	LUBRIZOL® 5160	5915	02 March 2005	November 2, 2006
The Lubrizol Corporation, Wickliffe, Ohio	LUBRIZOL® 779	5963	16 February 2006	December 2, 2006
The Lubrizol Corporation, Wickliffe, Ohio	LUBRIZOL® 5784S	5966	16 February 2006	December 2, 2006
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta	OilZone AE	6020	July 5, 2004	October 11, 2006
Innovative Chemical Technologies Canada Ltd., Calgary, Alberta	GasZone ITR	6021	July 5, 2004	October 11, 2006
InteliCoat Technologies, South Hadley, Massachusetts	Part No. 62025	6022	10/31/05 (English/ anglaise) 2004-06-19 (French/ française)	November 17, 2006
InteliCoat Technologies, South Hadley, Massachusetts	Part No. 66310	6023	10/31/05 (English/ anglaise) 2004-06-18 (French/ française)	November 17, 2006
Nalco Canada Co., Burlington, Ontario	NONEMULSIFYING AGENT W54	6032	2006/04/02	December 13, 2006
Hercules Canada Inc., formerly/ antérieurement Hercules Canada (2002) Inc., Mississauga, Ontario	PROSOFT® TQ-L67 TOPICAL LOTION	6042	18-Jan-2005	December 12, 2006
Innospec Fuel Specialties, formerly/ antérieurement Octel Starreon LLC, Newark, Delaware	DGS-138 formerly/ antérieurement Octel Starreon DGS-138	6053	09/07/2004	November 2, 2006
Hexion Specialty Chemicals Canada Inc., formerly/ antérieurement Borden Chemical - Canada, Division of the Borden Company, Limited, Oshawa, Ontario	Fentak™ CT0234	6057	08/05/2005	November 30, 2006
3M Canada Company, London, Ontario	3M(TM) HEAVY DRIP-CHECK(TM) SEALER, P.N. 08531	6078	08/10/2004	October 12, 2006
Nalco Canada Co., Burlington, Ontario	NALCO® VX8086SQ (FDP-S747-04) formerly/ antérieurement NALCO® VX8086SQ	6090	2006/04/18	October 18, 2006
Hercules Canada Inc., formerly/ antérieurement Hercules Canada (2002) Inc., Mississauga, Ontario	Prosoft® TQ230 Debonder	6095	14-MAR-2006	December 12, 2006
3M Canada Company, London, Ontario	SCOTCH-WELD(TM) EPOXY ADHESIVE DP-420 BLACK (PART A)	6115	17/12/2004	October 31, 2006
Cognis Canada Corporation, Mississauga, Ontario	STABIFLEX WP	6133	01/17/2005	December 11, 2006
Cytec Industries Inc., West Paterson, New Jersey	CYLINK® 2000 Crosslinking Agent	6146	03/01/2005	November 21, 2006
Cytec Industries Inc., West Paterson, New Jersey	FM® 1000 EP-15 Adhesive Film	6217	04/08/2005	December 14, 2006
Cytec Industries Inc., West Paterson, New Jersey	CYCOM® 799H STRUCTURAL RESIN	6219	04/07/2005	October 31, 2006
Rohm and Haas Canada LP, West Hill, Ontario	PARALOID KM-362 Powder	6587	04/27/2006	November 30, 2006

Notes: 1. The Notice of Filing published in the Canada Gazette, Part I, on March 13, 2004, listed the subject of the claim bearing Registry Number 5833 to be the chemical identity and concentration of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.

2. The Notice of Filing published in the Canada Gazette, Part I, on March 13, 2004, listed the subject of the claim bearing Registry Number 5889 to be the chemical identity and concentration of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.

3. The Notice of Filing published in the Canada Gazette, Part I, on July 17, 2004, listed the subject of the claim bearing Registry Number 5906 to be the chemical identity and concentration of one ingredient. The subject of the claim on which the screening officer issued the decision is the chemical identity of one ingredient.

4. The Notice of Filing published in the Canada Gazette, Part I, on July 17, 2004, listed the subject of the claim bearing Registry Number 5915 to be the chemical identity of two ingredients in English and the chemical identity of one ingredient in French. The correct subject of the claim and that on which the screening officer issued the decision is the chemical identity of two ingredients.

5. The Notice of Filing published in the Canada Gazette, Part I, on July 17, 2004, listed the subjects of the claims bearing Registry Numbers 5963 and 5966 to be the chemical identities of two and three ingredients, respectively. The subjects of the claims on which the screening officer issued the decisions are the chemical identities of one and two ingredients, respectively.

6. The Notice of Filing published in the Canada Gazette, Part I, on December 11, 2004, listed the subjects of the claims bearing Registry Numbers 6022 and 6023 to be the chemical identities of two and three ingredients, respectively. The subjects of the claims on which the screening officer issued the decisions are the chemical identities of one and two ingredients, respectively.

7. The Notice of Filing published in the Canada Gazette, Part I, on December 11, 2004, listed the subject of the claim bearing Registry Number 6042 to be the chemical identity of three ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of four ingredients.

8. The Notice of Filing published in the Canada Gazette, Part I, on November 12, 2005, listed the subject of the claim bearing Registry Number 6217 to be the chemical identity of two ingredients. The subject of the claim on which the screening officer issued the decision is the chemical identity of three ingredients.

There were no submissions from affected parties to the screening officer with respect to any of the above claims for exemption and related MSDSs.

Each of the claims for exemption listed above was found to be valid with the exception of the claims bearing Registry Numbers 6020 and 6021 which were found to be partially valid. The screening officer reached this decision after reviewing the information in support of the claim, having regard exclusively to the criteria found in section 3 of the Hazardous Materials Information Review Regulations. Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDS relating to the claims bearing Registry Numbers 5798 and 6587 complied with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

Having regard for the various data readily available in the literature and any information provided by the claimant, the screening officer found that the respective MSDS in respect of which the remaining claims were filed did not comply with the applicable disclosure requirements of the Hazardous Products Act and the Controlled Products Regulations.

Registry Numbers 5654, 5655 and 5678

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose correct information concerning the odour threshold of the chemical;

2. Registry Number 5678: Disclose that this ingredient has been shown to cause respiratory sensitization in workers.

Registry Number 5709

The claimant has been ordered to amend certain aspects of the format of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose LD₅₀ values for two of the confidential hazardous ingredients in an acceptable manner;

2. Disclose that diethylaminoethanol has been shown to be corrosive to the eyes of laboratory animals;

3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 30 minutes while taking care not to rinse contaminated water into the unaffected eye or face. Obtain medical advice immediately;

4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement "Dilute contents of stomach using 3-4 glasses milk or water" and add information to the effect that fluid is to be administered only under medical supervision. Disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

5. Add oxides of carbon, nitrogen and sulfur to the list of hazardous thermal decomposition products;

6. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause adverse effects on the brain, heart and the male reproductive system of laboratory animals;

7. Disclose that an ingredient in the controlled product has shown positive results in in vivo screening tests for mutagenicity;

8. Disclose that an ingredient in the controlled product has been shown to cause fetotoxic and teratogenic effects in humans;

9. Disclose that n-butyraldoxime, manganese chloride and halogenated hydrocarbons exhibit toxicological synergism in combination with an ingredient in the controlled product;

10. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2A.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Numbers 5799 and 5800

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for at least 30 minutes;

2. In relation to the first aid information shown on the MSDS for ingestion, add a statement such as the following: If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration;

3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for at least 30 minutes while taking care not to rinse contaminated water into the unaffected eye or face. Obtain medical advice immediately.

Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.

Registry Numbers 5830 and 5833

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Clarify the irritation potential of the controlled product as regards skin contact;

2. Registry Number 5833: In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed for at least 20 minutes or until the chemical is removed.

Registry Number 5852

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Remove the concentration range shown for the confidential hazardous ingredient;

2. Add oxides of nitrogen to the list of hazardous combustion products.

Registry Number 5878

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of diethylene glycol, monomethyl ether in the controlled product, its CAS registry number 111-77-3 and its percent concentration;

2. Disclose an LD₅₀ (oral, rat) range of 5 to 10 mL/kg for solvent naphtha (petroleum) heavy aromatic;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in bacterial cells, in vitro;

5. Disclose that an ingredient in the controlled product has been shown to cause adverse effects on the fetal development of laboratory animals.

Registry Number 5889

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 5891

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Remove the concentration range shown for the confidential hazardous ingredient;

2. Add oxides of nitrogen to the list of hazardous combustion products.

Registry Number 5896

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose an LD₅₀ (oral, rat) value of 3 200 mg/kg for solvent naphtha, petroleum, heavy aromatic;

2. Disclose that inhalation of an ingredient in the controlled product has been shown to cause fetotoxicity and postnatal developmental toxicity in laboratory animals;

3. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in bacterial cells, in vitro.

Registry Number 5903

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 5906

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 5907

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Add oxides of nitrogen to the list of hazardous combustion products.

Registry Number 5915

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Registry Number 5963

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one glass of water to drink;

2. Add oxides of nitrogen to the list of hazardous thermal decomposition products;

3. Disclose an LC₅₀ (4 hours, female rat) value of 5 060 ppm for toluene;

4. Disclose that chronic inhalation of an ingredient in the controlled product has caused colour vision loss in humans and has been shown to cause hearing loss in laboratory animals;

5. Disclose that acetylsalicylic acid and hexane synergistically enhance the hearing loss caused by inhalation exposure to toluene in laboratory animals.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 5966

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give one glass of water to drink;

2. Disclose that an ingredient in the controlled product is an eye irritant and remove the statement that the controlled product does not meet the criteria for a classification of D2B as an eye irritant.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Numbers 6020 and 6021

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the chemical identities and CAS numbers of the ingredients called alcohol 1 and alcohol 2;

2. Add eye contact as a route of entry;

3. Disclose a lower LD₅₀ value for one of the confidential hazardous ingredients;

4. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped.

Acknowledgement: Subsequent to the review of the MSDSs-of-Record respecting these particular claims, the claimant provided the Commission with copies of revised versions. These revised versions of the MSDSs were not, however, reviewed by the screening officer.

Registry Numbers 6022 and 6023

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of the confidential hazardous ingredients in an acceptable manner;

2. In relation to the first aid information shown on the MSDS for ingestion, delete the statement "Give 3-4 glasses of water";

3. Disclose an LD₅₀ (oral, rat) value of 350 mg/kg for ammonia;

4. Disclose that an ingredient in the controlled product has been shown to cause mutagenic effects in human and bacterial cells, in vitro;

5. Registry Number 6022:

(a) Add oxides of nitrogen to the list of hazardous combustion products;

(b) Disclose a lower LD₅₀ (oral, rat) value of 3 739 mg/kg for the confidential hazardous ingredient;

6. Registry Number 6023:

(a) In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with large quantities of water for at least 30 minutes;

(b) Disclose a lower LD₅₀ (oral, rat) value of 3 739 mg/kg for one of the confidential hazardous ingredients;

(c) Disclose a lower LD₅₀ (oral, rat) value of 1 200 mg/kg for the second of the confidential hazardous ingredients.

Registry Number 6032

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Correct the implication that naphthalene is an ingredient of the controlled product;

2. In relation to the first aid information shown on the MSDS for ingestion, disclose advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration. Also disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

3. If the WHMIS classifications are stated on the MSDS, disclose that the controlled product is also in class D2B.

Registry Number 6042

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the presence of an additional hazardous ingredient in the controlled product, together with its percent concentration and Exposure Limit Value;

2. Disclose that the quaternary amine has been shown to cause dermal sensitization in laboratory animals.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6053

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose oxides of carbon as hazardous combustion products.

Registry Number 6057

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Disclose that an ingredient in the controlled product has shown positive results in a screening test for mutagenicity;

2. In relation to the first aid information shown on the MSDS for ingestion, modify or remove the statement to give water to drink;

3. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes;

4. Disclose which types of extinguishers or firefighting agents are suitable for use on the burning product;

5. Add oxides of carbon, formaldehyde and hydrogen cyanide to the list of hazardous decomposition products.

Registry Number 6078

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed for at least 20 minutes or until the chemical is removed;

2. In relation to the first aid information shown on the MSDS for ingestion and inhalation, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

3. Disclose the lower LC₅₀ (4 hours, female rat) value of 19.0 mg/L for toluene;

4. Disclose the Exposure Limit Value ACGIH TLV-TWA = 50 ppm (skin) for toluene;

5. Disclose an LD₅₀ (dermal, male rabbit) value of 9.51 mL/kg for n-amyl acetate;

6. Disclose that chronic inhalation of an ingredient in the controlled product has been shown to cause adverse effects on the lungs of laboratory animals;

7. Disclose that chronic inhalation of an ingredient in the controlled product has caused colour vision loss in humans and has been shown to cause hearing loss in laboratory animals;

8. Disclose that chronic ingestion of an ingredient in the controlled product has been shown to cause hearing loss in laboratory animals;

9. Disclose that acetylsalicylic acid and hexane synergistically enhance the hearing loss caused by inhalation exposure to toluene in laboratory animals;

10. Disclose that a second ingredient in the controlled product has been shown to cause teratogenic effects in laboratory animals at maternally toxic dose levels.

Registry Number 6090

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Correct the impression that naphthalene and 1,2,4-trimethylbenzene are regulated components of the controlled product;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 15 minutes or until the chemical is removed;

3. In relation to the first aid information shown on the MSDS for ingestion, disclose a statement such as the following: Never give anything by mouth if the casualty is rapidly losing consciousness, or is unconscious or convulsing. If vomiting occurs naturally, have casualty lean forward to reduce the risk of aspiration.

Registry Number 6095

The claimant has been ordered to amend certain aspects of the format and content of the MSDS.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6115

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been ordered to amend the MSDS as indicated below.

1. Delete the statement that amorphous silica is not WHMIS regulated and disclose the proper chemical identity for amorphous silica as follows: siloxanes and silicones, di-methyl, reaction products with silica, CAS No. 67762-90-7;

2. In relation to the first aid information shown on the MSDS for eye contact, disclose a statement to the effect that the eyes should be flushed continuously with water for 30 minutes;

3. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be flushed with water for at least 30 minutes;

4. In relation to the first aid information shown on the MSDS for ingestion, remove the statement to give two glasses of water and add advice to the effect that the casualty should lean forward should vomiting occur in order to reduce the risk of aspiration;

5. Add oxides of sulphur to the list of hazardous combustion products;

6. Disclose an LC₅₀ (1 hour, rat, dust) range of 1.26 mg/L to 2.83 mg/L for amorphous silica;

7. Disclose that an ingredient in the controlled product has shown positive results in screening tests for mutagenicity.

Registry Number 6133

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. In relation to the first aid information shown on the MSDS for inhalation, disclose a statement to the effect that trained personnel should immediately administer artificial respiration or cardiopulmonary resuscitation if breathing has stopped or the heart has stopped;

2. Add hydrogen cyanide and oxides of nitrogen to the list of hazardous combustion products;

3. Disclose that polyisocyanate has been shown to cause respiratory sensitization in workers.

Registry Number 6146

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentration of tris carbamoyl carbazine in an acceptable manner;

2. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed.

Registry Number 6217

The claimant has been ordered to amend certain aspects of the content of the MSDS.

In the opinion of the screening officer, certain information should have been shown on the MSDS. The claimant has been further ordered to amend the MSDS as indicated below.

1. Disclose the percent concentrations of aminotriazine derivative (melamine) and titanium dioxide in an acceptable manner;

2. Disclose the presence of an additional confidential hazardous ingredient in the controlled product, together with its percent concentration;

3. Disclose the specific chemical identity of melamine for the hazardous ingredient currently identified on the MSDS as aminotriazine derivative;

4. In relation to the first aid information shown on the MSDS for skin contact, disclose a statement to the effect that the skin should be washed with water for 20 minutes or until the chemical is removed.

Acknowledgement: Subsequent to the review of the MSDS-of-Record respecting this particular claim, the claimant provided the Commission with a copy of a revised version. This revised version of the MSDS was not, however, reviewed by the screening officer.

Registry Number 6219

The claimant has been ordered to amend certain aspects of the content of the MSDS.

Having regard to the foregoing, and pursuant to sections 16 and 17 of the Hazardous Materials Information Review Act, notice is hereby given that the screening officer has, for the claims bearing registry numbers 6020 and 6021, directed the claimant to comply with the provisions of the Hazardous Products Act and the Controlled Products Regulations within 30 days from the expiry of the appeal period, including disclosing the identities of three and two ingredients respectively which were included among the information in respect of which the claims for exemption were made, and to provide a copy of the amended MSDS to the screening officer within 40 days of expiry of the appeal period.

Having regard to the foregoing, and pursuant to section 17 of the Hazardous Materials Information Review Act, notice is hereby given that the screening officer has, for each of the remaining above-noted claims, with the exceptions of those claims bearing registry numbers 5798 and 6587, directed the claimant to comply with the provisions of the Hazardous Products Act and the Controlled Products Regulations within 30 days from the expiry of the appeal period, except that the information in respect of which the claim for exemption was made does not have to be disclosed, and to provide a copy of the amended MSDS to the screening officer within 40 days of expiry of the appeal period.

Pursuant to paragraph 18(1)(b) of the Hazardous Materials Information Review Act, this notice includes certain information which, in the opinion of the screening officer, should have been shown on the relevant MSDS or label.

Pursuant to subsection 24(1) of the Controlled Products Regulations, amended MSDSs must be available in both official languages.

Section 20 of the Hazardous Materials Information Review Act affords the opportunity to a claimant or any affected party, within the meaning of subsection 2(2) of the Hazardous Materials Information Review Regulations, to appeal a decision or order of a screening officer. To initiate the appeal process, a Statement of Appeal (Form 1) as prescribed by the Hazardous Materials Information Review Act Appeal Board Procedures Regulations must be completed and delivered within 45 days of the publication of this notice in the Canada Gazette, Part I, to the acting Chief Appeals Officer at the following address: Hazardous Materials Information Review Commission, 427 Laurier Avenue W, 7th Floor, Ottawa, Ontario K1A 1M3, 613-993-4472.

R. BOARDMAN
Chief Screening Officer

[2-1-o]